Skip to main content

Advertisement

SpringerLink
Log in

Caring for Adult Survivors of Childhood Cancer

  • Pediatric Malignancies
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Improved survival for pediatric oncology patients is a remarkable achievement of modern medicine. This success can be credited to the introduction of multimodality therapy and newer risk-based therapies developed and tested through national research protocols. With improved survival has come recognition of the many long-term effects of cancer and its treatment, such as vital organ dysfunction, subsequent malignancies, and psychosocial deficits. Childhood cancer survivors are vulnerable to adverse health outcomes which may not become apparent until years after therapy. These events may manifest well into adulthood when these individuals rarely return to their initial cancer center or seek preventive medical care. Risk-based follow-up can offer early detection and/or intervention and provides an opportunity to reduce cancer-related morbidity and mortality. An understanding of the late effects of cancer therapy is increasingly important for the medical community, both generalists and specialists—adult and pediatric, to better care for the growing population of adult survivors of childhood cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hewitt M, Weiner SL, Simone JV: Childhood Cancer Survivorship Improving Care and Quality of Life. Washington, D.C., The National Academies Press, 2003

    Google Scholar 

  2. Hudson MM, Mertens AC, Yasui Y, et al.: Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 2003, 290:1583–1592

    Article  PubMed  CAS  Google Scholar 

  3. Mertens AC, Yasui Y, Neglia JP, et al.: Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001, 19:3163–3172

    PubMed  CAS  Google Scholar 

  4. Oeffinger KC, Mertens AC, Hudson MM, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2004, 2:61–70

    Article  PubMed  Google Scholar 

  5. Kadan-Lottick NS, Robison LL, Gurney JG, et al. Childhood cancer survivors’ knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA 2002, 287:1832–1839

    Article  PubMed  Google Scholar 

  6. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572–1582

    Article  PubMed  CAS  Google Scholar 

Analysis from the Childhood Cancer Survivor Study describing the frequency and severity of chronic health␣conditions among adult survivors of childhood cancer.

  1. Nathan PC, Greenberg ML, Ness KK, et al.: Risk-Based Care in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS). Annual Meeting of the American Society of Clinical Oncology. 2007 American Society of Clinical Oncology Annual Meeting Proceedings Part 1. Chicago, IL: American Society of Clinical Oncology; 2007:6502

  2. Kremer LC, van der Pal HJ, Offringa M, et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 2002, 13:819–829

    Article  PubMed  CAS  Google Scholar 

  3. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005, 23:2629–2636

    Article  PubMed  CAS  Google Scholar 

  4. Alvarez JA, Scully RE, Miller TL, et al. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr 2007, 19:23–31

    Article  PubMed  Google Scholar 

  5. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. Pediatrics 2008, 121:e387–396

    Article  PubMed  Google Scholar 

  6. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 2001, 19:191–196

    PubMed  CAS  Google Scholar 

  7. Ali MK, Ewer MS, Gibbs HR, et al. Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection. Cancer 1994, 74:182–188

    Article  PubMed  CAS  Google Scholar 

  8. Katz A, Goldenberg I, Maoz C, et al. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. Am J Med Sci 1997, 314:399–400

    Article  PubMed  CAS  Google Scholar 

  9. Hull MC, Morris CG, Pepine CJ, et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290:2831–2837

    Article  PubMed  CAS  Google Scholar 

  10. Berry GJ, Jorden M: Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer 2005, 44:630–637

    Article  PubMed  Google Scholar 

  11. Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 2004, 22:3139–3148

    Article  PubMed  Google Scholar 

  12. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 1993, 270:1949–1955

    Article  PubMed  CAS  Google Scholar 

  13. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. J Clin Oncol 1993, 11:1208–1215

    PubMed  CAS  Google Scholar 

  14. Lipshultz SE, Colan SD: Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol 2004, 22:769–773

    Article  PubMed  Google Scholar 

  15. Cardinale D, Colombo A, Sandri MT, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 2006, 114:2474–2481

    Article  PubMed  CAS  Google Scholar 

  16. Silber JH, Cnaan A, Clark BJ, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 2004, 22:820–828

    Article  PubMed  CAS  Google Scholar 

  17. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 2002, 20:4517–4522

    Article  PubMed  CAS  Google Scholar 

  18. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006, 107:1303–1312

    Article  PubMed  CAS  Google Scholar 

  19. Nuver J, Smit AJ, Postma A, et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 2002, 28:195–214

    Article  PubMed  CAS  Google Scholar 

Review of the metabolic syndrome among cancer survivors. Authors explore potential causes and preventive measures.

  1. Chow AY, Chin C, Dahl G, et al. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol 2006, 24:925–928

    Article  PubMed  CAS  Google Scholar 

  2. Aplenc R, Blanco J, Leisenring W, et al.: Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS). 2006 ASCO Annual Meeting Proceedings, Part 1. Atlanta, GA; 2006

  3. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006, 24:5277–5282

    Article  PubMed  Google Scholar 

  4. Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin’s Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005, 23:6508–6515

    Article  PubMed  Google Scholar 

  5. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, et al. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 2003, 88:3682–3689

    Article  PubMed  CAS  Google Scholar 

  6. Follin C, Thilen U, Ahren B, et al. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 2006, 91:1872–1875

    Article  PubMed  CAS  Google Scholar 

  7. Murray RD, Darzy KH, Gleeson HK, et al. GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 2002, 87:129–135

    Article  PubMed  CAS  Google Scholar 

  8. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002, 87:3136–3141

    Article  PubMed  CAS  Google Scholar 

  9. Ergun-Longmire B, Mertens AC, Mitby P, et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006, 91:3494–3498

    Article  PubMed  CAS  Google Scholar 

  10. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000, 85:3227–3232

    Article  PubMed  CAS  Google Scholar 

  11. Madanat LM, Lahteenmaki PM, Alin J, et al. The natural history of thyroid function abnormalities after treatment for childhood cancer. Eur J Cancer 2007, 43:1161–1170

    Article  PubMed  CAS  Google Scholar 

  12. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005, 365:2014–2023

    Article  PubMed  Google Scholar 

  13. Darzy KH, Shalet SM: Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005, 8:203–211

    Article  PubMed  Google Scholar 

Review of the effects of CNS neoplasms and radiation therapy on the hypothalamic-pituitary axis. Authors describe the pathophysiology and risks for dysfunction in each of the anterior pituitary hormones.

  1. Kenney LB, Laufer MR, Grant FD, et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001, 91:613–621

    Article  PubMed  CAS  Google Scholar 

  2. Williams D, Crofton PM, Levitt G: Does ifosfamide affect gonadal function? Pediatr Blood Cancer 2008, 50:347–351

    Article  PubMed  Google Scholar 

  3. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, et al. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003, 88:3149–3154

    Article  PubMed  CAS  Google Scholar 

  4. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2001, 23:424–430

    Article  PubMed  CAS  Google Scholar 

  5. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000, 356:993–997

    Article  PubMed  CAS  Google Scholar 

  6. Hoffman KE, Derdak J, Bernstein D, et al. Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 2008, 50:341–346

    Article  PubMed  Google Scholar 

  7. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001, 93:618–629

    Article  PubMed  CAS  Google Scholar 

Review of the frequency and risks for subsequent neoplasms within a large cohort of childhood cancer survivors.

  1. Jazbec J, Ecimovic P, Jereb B: Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004, 42:574–581

    Article  PubMed  Google Scholar 

  2. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005, 23:3733–3741

    Article  PubMed  Google Scholar 

  3. Bhatia S, Sklar C: Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002, 2:124–132

    Article  PubMed  Google Scholar 

  4. Dann EJ, Rowe JM: Biology and therapy of secondary leukaemias. Best Pract Res Clin Haematol 2001, 14:119–137

    Article  PubMed  CAS  Google Scholar 

  5. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004, 141:590–597

    PubMed  Google Scholar 

  6. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75–89

    Article  PubMed  Google Scholar 

  7. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006, 98:1528–1537

    Article  PubMed  Google Scholar 

A nested case–control study within the Childhood Cancer Survivor Study describing the frequency and risks for subsequent primary CNS neoplasms among childhood cancer survivors.

  1. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005, 23:2272–2279

    Article  PubMed  Google Scholar 

  2. Rourke MT, Hobbie WL, Schwartz L, et al. Posttraumatic stress disorder (PTSD) in young adult survivors of childhood cancer. Pediatr Blood Cancer 2007, 49:177–182

    Article  PubMed  Google Scholar 

  3. Taieb O, Moro MR, Baubet T, et al. Posttraumatic stress symptoms after childhood cancer. Eur Child Adolesc Psychiatry 2003, 12:255–264

    Article  PubMed  Google Scholar 

Review of 20 studies evaluating posttraumatic stress symptoms and/or posttraumatic stress disorder (PTSD) in childhood cancer survivors and/or their parents. Authors discuss implications of using posttraumatic stress model to advance understanding of psychopathological reactions of survivors and parents to inform health promoting interventions.

  1. Barakat LP, Alderfer MA, Kazak AE: Posttraumatic growth in adolescent survivors of cancer and their mothers and fathers. J Pediatr Psychol 2006, 31:413–419

    Article  PubMed  Google Scholar 

  2. Zebrack BJ, Chesler MA: Quality of life in childhood cancer survivors. Psychooncology 2002, 11:132–141

    Article  PubMed  Google Scholar 

  3. Kazak AE, Rourke MT, Alderfer MA, et al. Evidence-based assessment, intervention and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment. J Pediatr Psychol 2007, 32:1099–1110

    Article  PubMed  Google Scholar 

  4. Moore BD III (2005) Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 30:51–63

    Article  PubMed  Google Scholar 

Review of literature evaluating neurocognitive outcomes in survivors of pediatric cancer. Author addresses challenging methodological issues facing researchers and provides recommendations for future research directions that will facilitate identification of individual patients at risk for neurocognitive morbidity and development of cognitive rehabilitation research.

  1. Mulhern RK, Butler RW: Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004, 7:1–14; discussion 15–16

    Article  PubMed  Google Scholar 

  2. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005, 23:5511–5519

    Article  PubMed  Google Scholar 

  3. Pang JW, Friedman DL, Whitton JA, et al. Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008, 50:104–110

    Article  PubMed  Google Scholar 

  4. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003, 349:640–649

    Article  PubMed  Google Scholar 

  5. Nagarajan R, Neglia JP, Clohisy DR, et al. Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study. Cancer 2003, 97:2554–2564

    Article  PubMed  Google Scholar 

  6. Punyko JA, Gurney JG, Scott Baker K, et al. Physical impairment and social adaptation in adult survivors of childhood and adolescent rhabdomyosarcoma: a report from the Childhood Cancer Survivors Study. Psychooncology 2007, 16:26–37

    Article  PubMed  Google Scholar 

  7. Ness KK, Mertens AC, Hudson MM, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med 2005, 143:639–647

    PubMed  Google Scholar 

  8. Ness KK, Wall MM, Oakes JM, et al. Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol 2006, 16:197–205

    Article  PubMed  Google Scholar 

  9. Park ER, Li FP, Liu Y, et al. Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2005, 23:9187–9197

    Article  PubMed  Google Scholar 

  10. Barrera M, Shaw AK, Speechley KN, et al. Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer 2005, 104:1751–1760

    Article  PubMed  Google Scholar 

  11. Mabbott DJ, Spiegler BJ, Greenberg ML, et al. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 2005, 23:2256–2263

    Article  PubMed  Google Scholar 

  12. Zebrack BJ, Zeltzer LK: Living beyond the sword of Damocles: surviving childhood cancer. Expert Rev Anticancer Ther 2001, 1:163–164

    Article  PubMed  CAS  Google Scholar 

  13. Langeveld NE, Ubbink MC, Last BF, et al. Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology 2003, 12:213–225

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Mulrooney was supported by the National Institute of Health K12 program (Grant 1K12RR023247, R. V. Luepker, MD, Principal Investigator), Bethesda, MD and the Children’s Cancer Research Fund, Minneapolis, MN. Dr. Hudson was supported in part by the Cancer Center Support (CORE) Grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC).

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Minnesota Cancer Center, Mayo Mail Code 484, 420 Delaware Street SE, Minneapolis, MN, 55455, USA

    Daniel A. Mulrooney MD, MS & Joseph P. Neglia MD, MPH

  2. University of Tennessee College of Medicine, Memphis, TN, 38163, USA

    Melissa M. Hudson MD

  3. Department of Oncology, Division of Cancer Survivorship, St. Jude Children’s Research Hospital, Mailstop 735, 332 North Lauderdale, Memphis, TN, 38105, USA

    Melissa M. Hudson MD

Authors
  1. Daniel A. Mulrooney MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph P. Neglia MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Melissa M. Hudson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel A. Mulrooney MD, MS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulrooney, D.A., Neglia, J.P. & Hudson, M.M. Caring for Adult Survivors of Childhood Cancer. Curr. Treat. Options in Oncol. 9, 51–66 (2008). https://doi.org/10.1007/s11864-008-0054-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-008-0054-4

Keywords

Search

Navigation